New Zealand markets open in 7 hours 19 minutes
  • NZX 50

    -6.08 (-0.05%)

    +0.0000 (+0.01%)

    -95.30 (-1.29%)
  • OIL

    +1.01 (+1.13%)
  • GOLD

    -24.50 (-1.25%)

Meta fine, Pfizer drug, retail earnings: Top headlines

Yahoo Finance Live anchors Akiko Fujita and Seana Smith break down Monday's top headlines, including Meta being fined $1.3 billion, Pfizer's weight loss study, and retailers set to report earnings on Tuesday.

Video transcript

AKIKO FUJITA: Well, it is closing time here at Yahoo Finance. Let's get you caught up on some of the biggest headlines of the day. Meta is being fined $1.3 billion by EU regulators who say the tech giant broke privacy laws when it sent European customer data to the US. Meta says it will appeal the decision. Meta shares ending the day slightly higher, though up about 1%.

SEANA SMITH: A peer review study suggesting that an oral weight loss drugs from Pfizer may work faster and be as effective as Novo Nordisk's Ozempic, which is an injection. Now, the news sent shares higher, with Pfizer closing the day up just about 5%.

AKIKO FUJITA: And looking ahead to tomorrow, we've got a long list of retailers set to report their quarterly results. Lowe's, Dick's Sporting Goods, BJ's, Wholesale, Williams-Sonoma, and Urban Outfitters, are among those reporting. And given what we've heard from Target and Home Depot, we're going to be listening closely to see if any of those retailers are also seeing consumers starting to turn a little more cautious with their spending.